Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.7 |
mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.7 |
mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |